|
15 Mar 2007 |
Optimer Pharmaceuticals Advances Difimicin into Phase 3 Clinical Trial
|
|
15 Mar 2007 |
Curis Selects First Development Candidate from its Targeted Cancer Drug Development Platform
|
|
15 Mar 2007 |
Valeant Pharmaceuticals Initiates Taribavirin Phase 2b Clinical Study
|
|
14 Mar 2007 |
Tyrima(TM) Demonstrates Good Safety Profile and Excellent Pharmacokinetic Properties
|
|
14 Mar 2007 |
FDA approves Tykerb(R) (lapatinib) in combination with Xeloda(R) (capecitabine) for the treatment of advanced or metastatic breast cancer in women who have progressed on prior therapy
|
|
14 Mar 2007 |
Spectrum Pharmaceuticals Reaches Special Protocol Assessment Agreement With FDA on Phase 3 Trials for EOquin(R)
|
|
14 Mar 2007 |
Active Biotech's I-3D micro-dosing clinical trial concluded
|
|
14 Mar 2007 |
Nektar Initiates Phase 1 Clinical Program Evaluating NKTR-102 (PEG-irinotecan) for Potential to Treat Patients with Refractory Solid Tumors
|
|
14 Mar 2007 |
Cellzome Receives First Milestone Payment for Alzheimer's Program From Ortho-McNeil Pharmaceutical, Inc
|
|
14 Mar 2007 |
Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement
|
|
14 Mar 2007 |
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
|
|
14 Mar 2007 |
Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa
|
|
14 Mar 2007 |
Memory Pharmaceuticals Commences Phase 2a Trial of MEM 3454 in Alzheimer's Disease
|
|
13 Mar 2007 |
TorreyPines Therapeutics Initiates Phase I Multiple Dose Clinical Trial of NGX267, A Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
|
|
13 Mar 2007 |
Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
|
|
13 Mar 2007 |
Depomed Files Investigational New Drug Application For Gabapentin Gr For The Treatment Of Postmenopausal Hot Flashes
|
|
13 Mar 2007 |
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
|
|
13 Mar 2007 |
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified Which Prevent Clear Interpretation of Results
|
|
10 Mar 2007 |
SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
|
|
10 Mar 2007 |
Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer
|
|
09 Mar 2007 |
Second lung cancer trial adds to positive data on AS1404
|
|
09 Mar 2007 |
Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
|
|
09 Mar 2007 |
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
|
|
08 Mar 2007 |
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
|
|
08 Mar 2007 |
Stemline Expands its Oncology Pipeline with Acquisition of Clinically Active Compound Directed to "Cancer Stem Cell" Target
|
